{"DataElement":{"publicId":"2677074","version":"1","preferredName":"Breast Carcinoma Transplantation Time Recurrent Disease Chemosensitivity Type","preferredDefinition":"A description of the sensitivity to chemotherapy of the recurrent breast cancer at the time of transplantation.","longName":"BRST_CA_CHEMSENS_TYP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2677059","version":"1","preferredName":"Breast Carcinoma Transplantation Time Recurrent Disease","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla._The grafting of tissues from one individual to another or place to place within a single individual._The continuum of experience in which events pass from the future through the present to the past._the return of a sign, symptom, or disease after a remission.","longName":"BRST_CRCN_RCR_DS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2475941","version":"1","preferredName":"Breast Carcinoma","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002","longName":"C4872","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11C95199-159B-5C1E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2676463","version":"1","preferredName":"Transplantation Time Recurrent Disease","preferredDefinition":"The grafting of tissues from one individual to another or place to place within a single individual.:the continuum of experience in which events pass from the future through the present to the past.:the return of a sign, symptom, or disease after a remission.","longName":"C15342:C25207:C38155","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3938A932-CA86-725A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-03","modifiedBy":"ONEDATA","dateModified":"2007-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39642512-C0C3-1778-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".Updated def for \"breast carcinoma\". No version needed. AK 9/18/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2486888","version":"1","preferredName":"Chemosensitivity Type","preferredDefinition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better._Something distinguishable as an identifiable class based on common qualities.","longName":"CHEM_SENS_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-23BA-52BE-E044-0003BA3F9857","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"},{"value":"Untreated","valueDescription":"Without Therapeutic Procedure","ValueMeaning":{"publicId":"2676532","version":"1","preferredName":"Without Therapeutic Procedure","longName":"2676532","preferredDefinition":"Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395037C6-23C9-52BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-23E2-52BE-E044-0003BA3F9857","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"},{"value":"Resistant","valueDescription":"Resistance","ValueMeaning":{"publicId":"2674643","version":"1","preferredName":"Resistance","longName":"2674643","preferredDefinition":"Failure of a cancer to shrink after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resistance","conceptCode":"C19391","definition":"Failure of a cancer to shrink after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"384C7304-8808-48E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-23EE-52BE-E044-0003BA3F9857","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"},{"value":"Sensitive","valueDescription":"Sensitivity","ValueMeaning":{"publicId":"2676533","version":"1","preferredName":"Sensitivity","longName":"2676533","preferredDefinition":"A measure of the minimum change in an input signal that an instrument can detect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sensitivity","conceptCode":"C68816","definition":"A measure of the minimum change in an input signal that an instrument can detect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395037C6-23FC-52BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-2415-52BE-E044-0003BA3F9857","beginDate":"2006-06-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008570","version":"1","preferredName":"Personal attributes","preferredDefinition":"NCI Thesaurus code: CL003786: Personal Attribute\r\n","longName":"PERSONAL_ATTRIBUTES","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"B7FD1513-11B0-2714-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-03","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-03","modifiedBy":"SBREXT","dateModified":"2004-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2724589","version":"1","preferredName":"Chemosensitivity Type","preferredDefinition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.:Type; a subdivision of a particular kind of thing.","longName":"C71488:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemosensitivity","conceptCode":"C71488","definition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4455D875-2DF8-060D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-01-22","modifiedBy":"ONEDATA","dateModified":"2008-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"165D4F55-1DB3-1A89-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"pre_ted_brst_ca_sen_chemo","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"If the breast cancer was in t","type":"Preferred Question Text","description":"If the breast cancer was in the state of relapse at the time of transplantation, what was the sensitivity to chemotherapy?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2677074","type":"BRIDG Mapping Path","description":"PerformedDiagnosis [primary] > AssessedResultRelationship > PerformedObservation [assessment] > PerformedClinicalInterpretation.value [assessment] WHERE PerformedDiagnosis.value = \"breast cancer\" AND PerformedDiagnosis.diseaseStatusCode = \"relapse\" AND PerformedDiagnosis > PerformedObservation.dateRange IS LESS THAN PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Administer Hematopoietic Cell Product{ Transplantation} AND PerformedObservation [assessment] > DefinedObservation.name = \"Assess Chemotherpay Sensitivity\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39647EE3-01F5-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"KUMMEROA","dateModified":"2021-06-04","changeDescription":".2021-6-4 ak System generated def displayed as alt def. Updated def for \"breast carcinoma\". No version needed. AK 9/18/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}